Publication Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist's dilemma. Parajuli N, Poudyal Y. PLoS neglected tropical diseases. 2021; 15 (4) : e0009039. Download PDF
Publication Towards zero leprosy. Global leprosy (Hansen’s Disease) strategy 2021–2030 World Health Organization . 2021; Download PDF
Publication Leprosy incidence and risk estimates in a 33-year contact cohort of leprosy patients. Hacker M, Sales A, Duppre N, et al. Scientific reports. 2021; 11 (1) : 1947. Download PDF
Publication Leprosy post-exposure prophylaxis: innovation and precision public health. Moraes M, Düppre N. The Lancet. Global health. 2021; 9 (1) : e8-e9. Download PDF
Publication A Systematic Review of the Importance of Chemoprophylaxis and Immunoprophylaxis in Subclinical Case of Leprosy that can Reduce the Incidence and the Transmission of Leprosy Mulianto N, Sari ADAP, Kariosentono H, et al. European Journal of Molecular & Clinical Medicine. 2020; 7 (11) : 709-715. Download PDF
Publication Global consultation of National Leprosy Programme managers, partners and affected persons on Global Leprosy Strategy 2021–2030: Report of the virtual meeting 26-30 October 2020 WHO/Department of control of neglected tropical diseases . World Health Organization. 2020; Download PDF
Publication Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis World Health Organization . World Health Organization. 2020; Download PDF
Publication A comprehensive research agenda for zero leprosy Steinmann P, Dusenbury C, Addiss D, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2020; Download PDF
Publication The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis Schoenmakers A, Mieras L, Budiawan T, et al. Informa UK Limited. Research and Reports in Tropical Medicine. 2020; Download PDF
Publication Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy. Lenz S, Collins J, Ray N, et al. PLoS neglected tropical diseases. 2020; 14 (9) : e0008583. Download PDF
Publication Jopling's Handbook of Leprosy, 6/E Sardana K, Khurana A. CBS Publishers & Distributors. 2020; Download PDF
Publication CHEMOPROPHYLAXIS VERSUS IMMUNOPROPHYLAXIS IN TUBERCULOSIS AND LEPROSY INFECTION Novita BD. Jurnal Widya Medika. 2020; 6 (1) : 65-71.
Publication Report of the first meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases World Health Organization (WHO) . World Health Organization. 2020; Download PDF
Publication Potential Public Health Measures to Tackle Skin Diseases Mphande FA. Springer Singapore. Skin Disorders in Vulnerable Populations. 2020;
Publication Leprosy: Treatment and Management of Complications. Maymone M, Venkatesh S, Laughter M, et al. Journal of the American Academy of Dermatology. 2020;
Publication [Acceptability of chemoprophylaxis in an endemic area for leprosy: the PEP-Hans Brazil Project]. Cortela D, Ferreira S, Virmond M, et al. Cadernos de saude publica. 2020; 36 (3) : e00068719. Download PDF
Publication Preventing Leprosy: Epidemiological and immunological aspects of chemo- and immunoprophylaxis in leprosy patients’ contacts Richardus R. Leiden University. Leiden University of Medical Center. 2020; Download PDF
Publication Reply to: Single-dose rifampicin and BCG to prevent leprosy. Richardus JH, Geluk A. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020; Download PDF
Publication Single-dose rifampicin and BCG to prevent leprosy. Lockwood DN, De Barros B, Walker SL. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020; Download PDF
Publication Prevention of transmission of leprosy: The current scenario. Palit A, Kar H. Indian journal of dermatology, venereology and leprology. 2020; 86 (2) : 115-123. Download PDF
